ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.98
0.00%
US Tech 100
20,877.20
1.72%
S&P 500
5,996.66
1.00%
US Dollar vs CAD
1.44633
-0.08%
Bitcoin
106,942.43
3.71%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Cel Sci Corporation New (CVM)

  7. Cel Sci Corporation New (CVM) News

CVM

Cel Sci (CVM)

Cel Sci Corporation New
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:CVM
DateTimeSourceHeadlineSymbolCompany
01/14/20258:00AMBusiness WireCEL-SCI Reports Fiscal 2024 Results: Set to Commence Confirmatory Study That Could Bring New Standard of Care to Head & Neck CancerAMEX:CVMCel Sci Corporation New
01/13/20253:16PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]AMEX:CVMCel Sci Corporation New
01/03/20254:25PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:CVMCel Sci Corporation New
01/02/20251:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
01/02/20251:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
01/02/20251:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
12/31/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CVMCel Sci Corporation New
12/31/20243:05PMBusiness WireCEL-SCI Announces Closing of $5 Million OfferingAMEX:CVMCel Sci Corporation New
12/30/20244:05PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:CVMCel Sci Corporation New
12/30/20243:16PMEdgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405AMEX:CVMCel Sci Corporation New
12/29/20247:41PMBusiness WireCEL-SCI Announces Pricing of $5 Million Public OfferingAMEX:CVMCel Sci Corporation New
12/27/20244:05PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:CVMCel Sci Corporation New
12/27/20244:05PMBusiness WireCEL-SCI Announces Proposed Public Offering of Common StockAMEX:CVMCel Sci Corporation New
12/12/20248:15AMBusiness WireCEL-SCI Highlights Biological Rationale for the Use of Multikine in the Confirmatory Registration Head and Neck Cancer StudyAMEX:CVMCel Sci Corporation New
11/15/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CVMCel Sci Corporation New
11/13/20247:30AMEdgar (US Regulatory)Form 8-K - Current reportAMEX:CVMCel Sci Corporation New
11/07/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:CVMCel Sci Corporation New
11/07/20247:15AMBusiness WireU.S. FDA and CEL-SCI Agree on Use of PD-L1 Biomarker to Select Head and Neck Cancer Patients for Marketing Registration Study to Commence Q1 2025AMEX:CVMCel Sci Corporation New
10/30/20244:21PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:CVMCel Sci Corporation New
10/25/20244:17PMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:CVMCel Sci Corporation New
10/22/20248:15AMBusiness WireFDA’s Oncologic Drugs Advisory Committee Decision on Checkpoint Inhibitors Substantiates Potential of CEL-SCI’s Multikine® to Address Major Treatment Gap for PD-L1 Negative Cancer PatientsAMEX:CVMCel Sci Corporation New
10/11/20244:00PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementAMEX:CVMCel Sci Corporation New
10/10/20243:05PMEdgar (US Regulatory)Form AW - Amendment Withdrawal RequestAMEX:CVMCel Sci Corporation New
10/08/20244:13PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:CVMCel Sci Corporation New
10/01/20248:13AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
10/01/20248:05AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
10/01/20247:58AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CVMCel Sci Corporation New
10/01/20245:00AMBusiness WireCEL-SCI Selects Ergomed as CRO as it Gears Up for Confirmatory FDA Registration Study of Multikine® in Head and Neck CancerAMEX:CVMCel Sci Corporation New
09/16/20246:30AMBusiness WireCEL-SCI’s Multikine® Increased 5-Year Survival Rate to 82.6% in Locally Advanced Resectable Head & Neck Cancer Patients Who Were Deemed to be in the Treatment Group for Surgery and RadiationAMEX:CVMCel Sci Corporation New
09/10/20248:32AMBusiness WireCEL-SCI to Present New Data for Multikine® Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 CongressAMEX:CVMCel Sci Corporation New
 Showing the most relevant articles for your search:AMEX:CVM

Your Recent History

LSE
79PW
Qnb Fin 25
NASDAQ
RMCF
Rocky Mountain Chocolate...
NASDAQ
VFF
Village Farms
USOTC
ILIM
IL2M (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads